Stage III Melanoma


Investigational Melanoma Drug Shrinks Tumors in Phase III Trial (07-2-2013)

In a Phase III clinical trial, the investigational drug T-VEC (talimogene laherparepvec) produced durable responses in people with advanced melanoma.  These results were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology... Continue Reading

Anti-PD-1 Drugs Promising for Advanced Melanoma (07-1-2013)

In Phase I clinical trials, investigational drugs that target a protein known as PD-1 are showing promise for the treatment of advanced melanoma. Results from two of the trials were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading